Freja Herborg

Freja Herborg serves as Associate Professor in the Department of Neuroscience at the University of Copenhagen's Faculty of Health and Medical Sciences (SUND), where she conducts research within the Neuropharm and Genetics group and the Gether Lab (gether-lab). Her work focuses on molecular mechanisms of dopamine signaling, GPCR biology, and neurodegenerative processes in Parkinson's disease, utilizing advanced techniques including single-molecule microscopy and cellular reprogramming.

Her research interests span Neuroscience, Molecular Pharmacology, and Neurogenetics, with specific expertise in dopamine transporter dynamics, GPCR endocytosis, and neuronal reprogramming for therapeutic applications. She investigates how nanoscale organization of neuronal proteins influences neurotransmission and how genetic factors like Synaptojanin1 contribute to Parkinson's disease pathology.

Analysis of her 26 research outputs (2022-2025) reveals consistent emphasis on dopamine neuropharmacology and Parkinson's disease mechanisms, with frequent publication in high-impact journals like Science Advances and Nature Communications. Her work bridges molecular biology, neuroimaging, and translational research to develop novel therapeutic strategies.

Dr. Herborg operates within the internationally recognized Gether Lab, which specializes in neurotransmitter transporters and G protein-coupled receptors. The lab fosters interdisciplinary collaboration between molecular biologists, neuroscientists, and clinicians to address fundamental questions in neuropharmacology and neurodegeneration.